IIL pursues not only the mandate of NDDB to provide products and services to enhance the quality of livestock in the country but also use its technological capabilities to the benefit of the people of India. IIL strongly believes that its mission of "immunity made affordable" can be actively pursued only with a sound technology base in modern biotechnology.

IIL operates a facility in Ooty to manufacture the vero cell culture rabies vaccine for use in human beings. This plant was set up in 1998 at the specific request of the Government of India so that our country can phase out use of the older and unsafe sheep brain vaccine (also termed nerve tissue vaccine - NTV) with the
modern tissue culture vaccine.IIL sells the product under the brand name "Abhayrab" through its network of "Abhay Clinics".

IIL is the second company in the world to launch the purified vero cell rabies vaccine (PVRV).The vaccine is sold at very economical price when compared to the brands of multinational companies. The success of Abhayrab and Abhay Clinics emboldened IIL to build a new vaccine facility in Hyderabad to manufacture various other human vaccines such as Diphtheria, Pertussis, Tetanus, Recombinant Hepatitis B, Hepatitis A and Measles. This plant will also produce combination vaccine against these diseases.


-------------------------------------------------------------------------------------------------------------------